Pharmaceuticals - Western Asia

  • Western Asia
  • In 2024, the projected revenue in the Pharmaceuticals market in Western Asia is expected to reach US$22.10bn.
  • The largest market within this industry is Oncology Drugs, which is projected to have a market volume of US$3.93bn in 2024.
  • Looking ahead, the revenue is expected to grow at an annual rate of 4.80% (CAGR 2024-2029), resulting in a market volume of US$27.94bn by 2029.
  • It is worth noting that in global comparison, United States is expected to generate the highest revenue, with US$630.30bn in 2024.
  • In Western Asia, the pharmaceutical market is experiencing a surge in demand for innovative treatments and a focus on personalized medicine.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmaceuticals market in Western Asia has been rapidly developing in recent years.

Customer preferences:
Customers in Western Asia have shown a growing interest in pharmaceutical products due to an increase in healthcare awareness and a rise in chronic diseases. The preference for branded drugs has also increased due to the perception of higher quality and effectiveness.

Trends in the market:
The pharmaceutical market in Saudi Arabia has been growing due to an aging population and an increase in government spending on healthcare. The UAE has also seen a rise in demand for pharmaceutical products due to an increase in medical tourism. Iran has the largest pharmaceutical market in the region and has seen significant growth due to the government's focus on expanding the domestic pharmaceutical industry.

Local special circumstances:
The pharmaceutical market in Western Asia is heavily regulated, with strict laws and regulations governing the import, manufacture, and sale of pharmaceutical products. This has led to a limited number of players in the market, with multinational pharmaceutical companies dominating the market.

Underlying macroeconomic factors:
The growing population and increasing healthcare awareness in Western Asia have led to an increase in demand for pharmaceutical products. Government initiatives to improve healthcare infrastructure and expand access to healthcare services have also contributed to the growth of the pharmaceutical market in the region. Additionally, the rise in medical tourism in countries like the UAE has led to an increase in demand for pharmaceutical products.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)